Recurring Consumable Business ModelTarsons' core product set is consumable labware used across research, diagnostics, pharma and industrial labs. Consumables create repeat purchasing and predictable baseline revenue. This durable, usage-driven demand supports long-term revenue visibility and resilience versus one-off product sales.

Strong Top-line GrowthA ~32% year-over-year revenue increase signals meaningful market expansion or wallet-share gains. Sustained double-digit growth supports scale benefits, channel strengthening and the capacity to invest in manufacturing and distribution, which can entrench market position over the medium term.

Healthy Gross And EBITDA MarginsRelatively high gross and EBITDA margins indicate manufacturing control, favorable product mix and operational efficiency. These durable margins give room to fund R&D, distribution and working capital, and provide insulation against input cost volatility while supporting sustainable operating profitability.

Bears Say

Negative Free Cash FlowNegative free cash flow in 2025 is a structural concern: it limits internal funding for growth, dividends and debt reduction. Even with solid operating cash relative to net income, persistent FCF deficits reflect capex or working capital needs that may require external financing and constrain long-term financial flexibility.

Low Return On EquityAn ROE of 4.7% implies weak capital efficiency relative to peers. Despite revenue growth and decent margins, the company struggles to convert equity into attractive shareholder returns. This raises questions about capital allocation, pricing power, or cost structure that could impair long-term value creation.

Earnings Decline / EPS ContractionA ~32% decline in EPS and falling net income signal pressures on bottom-line sustainability. Persistent earnings contraction can erode reinvestment capacity and investor confidence. Structural issues like margin erosion, higher costs or inefficient scaling may be driving weaker profitability over time.

Tarsons Products Limited News

Tarsons Products Limited Releases Investor Presentation for Q2 2025

Tarsons Products Limited ( ($IN:TARSONS) ) has shared an announcement. Tarsons Products Limited has released its Investor Presentation...

4M ago

Tarsons Products Limited Announces Virtual AGM and Annual Report Release

Tarsons Products Limited ( ($IN:TARSONS) ) has issued an announcement. Tarsons Products Limited has announced the dissemination of...

7M ago

TARSONS FAQ

What was Tarsons Products Limited’s price range in the past 12 months?

Tarsons Products Limited lowest stock price was ₹176.05 and its highest was ₹457.25 in the past 12 months.

What is Tarsons Products Limited’s market cap?

Tarsons Products Limited’s market cap is ₹10.24B.

When is Tarsons Products Limited’s upcoming earnings report date?

Tarsons Products Limited’s upcoming earnings report date is May 25, 2026 which is in 70 days.

How were Tarsons Products Limited’s earnings last quarter?

Tarsons Products Limited released its earnings results on Feb 06, 2026. The company reported ₹0.5 earnings per share for the quarter, the consensus estimate of ₹0.5 by ₹0.

Is Tarsons Products Limited overvalued?

According to Wall Street analysts Tarsons Products Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Tarsons Products Limited pay dividends?

Tarsons Products Limited pays a Notavailable dividend of ₹2 which represents an annual dividend yield of 0.86%. See more information on Tarsons Products Limited dividends here

What is Tarsons Products Limited’s EPS estimate?

Tarsons Products Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Tarsons Products Limited have?

Tarsons Products Limited has 53,206,280 shares outstanding.

What happened to Tarsons Products Limited’s price movement after its last earnings report?

Tarsons Products Limited reported an EPS of ₹0.5 in its last earnings report, expectations of ₹0.5. Following the earnings report the stock price went up 7.105%.

Which hedge fund is a major shareholder of Tarsons Products Limited?

Currently, no hedge funds are holding shares in IN:TARSONS

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Tarsons Products Limited

Tarsons Products Limited engages in the manufacturing and trading of plastic laboratory products and scientific instruments in India and internationally. The company's products include disposable plastic labware, centrifuge ware, cryo labware, liquid handling systems, and safety products and instruments; and bottles, carboys, measuring cylinder, cell culture products, electrophoresis, microscopy and microbiology products, vacuum desiccators, mini coolers, cryo boxes, breakers, test tube racks, pipette tips, petri dish, centrifuge tubes, cryogenic and storage vials, pasteur pipettes, vortex, and other products. Its products are used in molecular biology, cell culture, genomics, proteomics, and immunology. The company was incorporated in 1983 and is headquartered in Kolkata, India.